Daewoong (003090) - Net Assets
Based on the latest financial reports, Daewoong (003090) has net assets worth ₩1.63 Trillion KRW (≈ $1.10 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩3.10 Trillion ≈ $2.10 Billion USD) and total liabilities (₩1.47 Trillion ≈ $994.79 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Daewoong to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩1.63 Trillion |
| % of Total Assets | 52.59% |
| Annual Growth Rate | 8.84% |
| 5-Year Change | 34.52% |
| 10-Year Change | 81.36% |
| Growth Volatility | 17.17 |
Daewoong - Net Assets Trend (2000–2024)
This chart illustrates how Daewoong's net assets have evolved over time, based on quarterly financial data. Also explore 003090 total assets for the complete picture of this company's asset base.
Annual Net Assets for Daewoong (2000–2024)
The table below shows the annual net assets of Daewoong from 2000 to 2024. For live valuation and market cap data, see 003090 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩1.50 Trillion ≈ $1.02 Billion |
+4.57% |
| 2023-12-31 | ₩1.44 Trillion ≈ $973.70 Million |
+12.29% |
| 2022-12-31 | ₩1.28 Trillion ≈ $867.10 Million |
+10.58% |
| 2021-12-31 | ₩1.16 Trillion ≈ $784.11 Million |
+3.59% |
| 2020-12-31 | ₩1.12 Trillion ≈ $756.92 Million |
+8.84% |
| 2019-12-31 | ₩1.03 Trillion ≈ $695.47 Million |
+6.42% |
| 2018-12-31 | ₩964.31 Billion ≈ $653.50 Million |
+2.66% |
| 2017-12-31 | ₩939.31 Billion ≈ $636.55 Million |
+8.64% |
| 2016-12-31 | ₩864.63 Billion ≈ $585.95 Million |
+4.36% |
| 2015-12-31 | ₩828.48 Billion ≈ $561.45 Million |
+16.90% |
| 2014-12-31 | ₩708.73 Billion ≈ $480.30 Million |
+3.15% |
| 2013-12-31 | ₩687.07 Billion ≈ $465.62 Million |
+75.54% |
| 2012-12-31 | ₩391.40 Billion ≈ $265.24 Million |
+16.45% |
| 2011-12-31 | ₩336.10 Billion ≈ $227.77 Million |
-30.66% |
| 2010-12-31 | ₩484.70 Billion ≈ $328.47 Million |
+12.88% |
| 2009-12-31 | ₩429.38 Billion ≈ $290.98 Million |
+4.08% |
| 2008-12-31 | ₩412.53 Billion ≈ $279.57 Million |
+13.50% |
| 2007-12-31 | ₩363.46 Billion ≈ $246.31 Million |
+23.56% |
| 2006-12-31 | ₩294.16 Billion ≈ $199.35 Million |
+17.13% |
| 2005-12-31 | ₩251.13 Billion ≈ $170.19 Million |
+12.78% |
| 2004-12-31 | ₩222.67 Billion ≈ $150.90 Million |
+4.06% |
| 2003-12-31 | ₩213.98 Billion ≈ $145.01 Million |
+4.10% |
| 2002-12-31 | ₩205.55 Billion ≈ $139.30 Million |
-10.14% |
| 2001-12-31 | ₩228.75 Billion ≈ $155.02 Million |
+16.35% |
| 2000-12-31 | ₩196.60 Billion ≈ $133.23 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Daewoong's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 94618088851000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩946.18 Billion | 94.95% |
| Other Components | ₩50.33 Billion | 5.05% |
| Total Equity | ₩996.51 Billion | 100.00% |
Daewoong Competitors by Market Cap
The table below lists competitors of Daewoong ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai Metersbonwe Fashion&Accessories Co Ltd
SHE:002269
|
$625.02 Million |
|
Zhongrui Co Ltd
SHE:301587
|
$625.20 Million |
|
RaySearch Laboratories AB (publ)
ST:RAY-B
|
$625.45 Million |
|
S.J.S. Enterprises Limited
NSE:SJS
|
$625.50 Million |
|
Anhui Zhonghuan Environmental Protection Technology Co Ltd
SHE:300692
|
$624.71 Million |
|
Guangbo Group Stock Co Ltd
SHE:002103
|
$624.67 Million |
|
Hindustan Construction Company Limited
NSE:HCC
|
$624.36 Million |
|
AMN Healthcare Services Inc
NYSE:AMN
|
$624.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Daewoong's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 934,796,127,920 to 996,506,946,100, a change of 61,710,818,180 (6.6%).
- Net income of 57,885,500,080 contributed positively to equity growth.
- Dividend payments of 8,194,805,000 reduced retained earnings.
- Other factors increased equity by 12,020,123,100.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩57.89 Billion | +5.81% |
| Dividends Paid | ₩8.19 Billion | -0.82% |
| Other Changes | ₩12.02 Billion | +1.21% |
| Total Change | ₩- | 6.60% |
Book Value vs Market Value Analysis
This analysis compares Daewoong's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.79x to 0.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩12611.48 | ₩22550.00 | x |
| 2018-12-31 | ₩13190.53 | ₩22550.00 | x |
| 2019-12-31 | ₩14533.69 | ₩22550.00 | x |
| 2020-12-31 | ₩16494.66 | ₩22550.00 | x |
| 2021-12-31 | ₩17576.91 | ₩22550.00 | x |
| 2022-12-31 | ₩19932.71 | ₩22550.00 | x |
| 2023-12-31 | ₩22813.07 | ₩22550.00 | x |
| 2024-12-31 | ₩24370.01 | ₩22550.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Daewoong utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.81%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.99%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 2.73x
- Recent ROE (5.81%) is below the historical average (10.65%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 9.61% | 7.19% | 0.67x | 1.99x | ₩-664.42 Million |
| 2001 | 15.08% | 10.71% | 0.80x | 1.76x | ₩9.91 Billion |
| 2002 | 15.08% | 5.01% | 0.87x | 3.44x | ₩4.70 Billion |
| 2003 | 5.70% | 2.49% | 0.89x | 2.56x | ₩-5.36 Billion |
| 2004 | 9.62% | 3.56% | 0.99x | 2.74x | ₩-476.95 Million |
| 2005 | 11.26% | 3.71% | 1.07x | 2.85x | ₩1.71 Billion |
| 2006 | 15.63% | 4.85% | 1.11x | 2.91x | ₩8.75 Billion |
| 2007 | 16.05% | 4.88% | 1.12x | 2.92x | ₩11.16 Billion |
| 2008 | 7.05% | 2.28% | 1.02x | 3.03x | ₩-6.66 Billion |
| 2009 | 8.31% | 2.61% | 1.09x | 2.93x | ₩-4.07 Billion |
| 2010 | 12.00% | 4.82% | 0.87x | 2.86x | ₩5.40 Billion |
| 2011 | 13.36% | 14.70% | 0.62x | 1.47x | ₩10.87 Billion |
| 2012 | 12.23% | 13.78% | 0.63x | 1.41x | ₩8.04 Billion |
| 2013 | 10.24% | 4.83% | 0.94x | 2.26x | ₩968.29 Million |
| 2014 | 5.53% | 2.66% | 0.88x | 2.35x | ₩-19.23 Billion |
| 2015 | 8.30% | 3.87% | 0.80x | 2.67x | ₩-7.92 Billion |
| 2016 | 4.08% | 1.95% | 0.69x | 3.02x | ₩-28.75 Billion |
| 2017 | 12.16% | 5.89% | 0.73x | 2.84x | ₩11.79 Billion |
| 2018 | 5.24% | 2.43% | 0.77x | 2.80x | ₩-27.10 Billion |
| 2019 | 9.95% | 4.57% | 0.82x | 2.66x | ₩-323.84 Million |
| 2020 | 14.35% | 7.26% | 0.74x | 2.68x | ₩29.85 Billion |
| 2021 | 10.79% | 5.21% | 0.78x | 2.65x | ₩5.75 Billion |
| 2022 | 12.37% | 6.04% | 0.79x | 2.60x | ₩19.68 Billion |
| 2023 | 16.33% | 8.42% | 0.77x | 2.52x | ₩59.19 Billion |
| 2024 | 5.81% | 2.99% | 0.71x | 2.73x | ₩-41.77 Billion |
Industry Comparison
This section compares Daewoong's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $401,390,357,055
- Average return on equity (ROE) among peers: 0.79%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Daewoong (003090) | ₩1.63 Trillion | 9.61% | 0.90x | $624.88 Million |
| Dongwha Pharm.Co.Ltd (000020) | $252.93 Billion | 10.38% | 0.28x | $113.83 Million |
| Yuhan Corp. (000100) | $407.93 Billion | 10.79% | 0.55x | $4.57 Billion |
| Yuhan Corp Preferred (000105) | $1.65 Trillion | 2.42% | 0.28x | $59.61 Million |
| Yuyu Pharma (000220) | $69.50 Billion | 3.97% | 0.28x | $46.55 Million |
| Yuyu Pharma Inc (000225) | $117.04 Billion | 1.10% | 0.32x | $17.67 Million |
| Yuyu Pharma Inc (000227) | $78.29 Billion | 7.52% | 0.42x | $42.93 Million |
| Ildong Holdings Co Ltd (000230) | $169.10 Billion | -60.53% | 4.10x | $76.14 Million |
| Samil Pharm (000520) | $127.83 Billion | 1.30% | 1.90x | $127.90 Million |
| Donga Socio Holdings (000640) | $875.86 Billion | 17.02% | 0.60x | $427.15 Million |
| Jw Pharmac (001060) | $265.44 Billion | 13.94% | 1.43x | $476.78 Million |
About Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more